Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Romidepsin in Metastatic Breast Cancer
NCT00098397Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Feb 2005
- Primary completion
- Sep 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of romidepsin in breast cancer, sponsored by National Cancer Institute. Started Feb 2005; status: completed.
02
Drugs
romidepsin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00098397.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00098397.